Novo Nordisk: Patenting Activity Novo Nordisks patent filing activity surged in 2017, coinciding with the U.S
The sister died of sudden cardiopulmonary arrest due to the increase of long-chain (C16-18) acylcarnitines
Although retatrutide's mechanism of action is designed to minimise the risk of hypoglycaemia when used as monotherapy, certain groups of patients may face a higher risk, particularly as the drug is being studied in populations already managing type 2 diabetes or obesity with existing medications
Poorly installed signage can be unsafe, and are susceptible to the elements, reducing the life of your investment for your business
In a case involving toxic exposure, Equity Partner Patrick A
The National Library of Medicine has reported that peptide breakdown becomes worse when storage conditions move away from ideal settings